proofvc

Weekly Roundup | 7/10/26

PROOF

July 10, 2026

A look at what's been happening across our portfolio this week:

DailyPay has been named the #1 Leader in Everest Group's 2026 U.S. B2B Earned Wage Access PEAK Matrix® Assessment, scored highest among all providers in Market Impact, Vision and Capability.
‍
Colossal Biosciences is partnering with Dr. Andrew Flies and the team at University of Tasmania to develop edible vaccine baits for Tasmanian devils. They are also exploring genetic tools that could help future generations resist devastating diseases such as a contagious cancer called devil facial tumor disease (DFTD).
‍
This week kicked off the founding cohort of MasterClass Executive, a new applied business program built in partnership with The University of Chicago Booth School of Business. Subjects range from Strategy & Operations to Financial & Data Intelligence and Product Innovation.

‍